Ishiura, Yoshihisa
100  Ergebnisse:
Personensuche X
?
 
?
5

Efficacy of Gefapixant, a P2X3 Antagonist, for Refractory A..:

Ishiura, Yoshihisa ; Nomura, Shosaku ; Ishii, Yuka...
International Medical Case Reports Journal.  16 (2023)  - p. 497-501 , 2023
 
?
6

Assessment of the pneumonia severity score in community-acq..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  29 (2023)  5 - p. 437-442 , 2023
 
?
7

Alectinib in a patient with ALK-positive non-small lung can..:

Ishiura, Yoshihisa ; Nomura, Shosaku ; Ishii, Yuka...
Journal of Oncology Pharmacy Practice.  29 (2023)  5 - p. 1283-1285 , 2023
 
?
8

Association of High Mobility Group Box-Protein 1 and Platel..:

Nomura, Shosaku ; Ichikawa, Jun ; Shimizu, Toshiki...
Clinical and Applied Thrombosis/Hemostasis.  29 (2023)  - p. , 2023
 
?
9

Validation of JRS atypical pneumonia score in patients with..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  29 (2023)  9 - p. 863-868 , 2023
 
?
11

Efficacy of gefapixant, a P2X3 antagonist, for lung cancer-..:

Ishiura, Yoshihisa ; Nomura, Shosaku ; Ishii, Yuka...
Journal of International Medical Research.  51 (2023)  8 - p. , 2023
 
?
12

Changes in diagnostic usefulness of the JRS scoring system ..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  28 (2022)  10 - p. 1375-1379 , 2022
 
?
13

Early identification of novel coronavirus (COVID-19) pneumo..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  28 (2022)  5 - p. 718-721 , 2022
 
?
14

Clinical features of nursing and healthcare-associated pneu..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  28 (2022)  7 - p. 902-906 , 2022
 
?
15

A warning related to predicting the severity of COVID-19 pn..:

Miyashita, Naoyuki ; Nakamori, Yasushi ; Ogata, Makoto...
Journal of Infection and Chemotherapy.  28 (2022)  2 - p. 359-360 , 2022
 
1-15